BioSenic S.A. (BIOS) - Cash Flow Conversion Efficiency

Latest as of December 2024: 0.052x

Based on the latest financial reports, BioSenic S.A. (BIOS) has a cash flow conversion efficiency ratio of 0.052x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.39 Million ≈ $-1.62 Million USD) by net assets (€-26.81 Million ≈ $-31.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BIOS company net worth for the company's overall valuation and market capitalisation.

BioSenic S.A. - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how BioSenic S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

BioSenic S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioSenic S.A. ranked by their cash flow conversion efficiency. Explore BioSenic S.A. cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Reinhold Europe AB WAR:RHD	0.023x
Phoenix Spree Deutschland Ltd LSE:PSDL	0.012x
Triangle Energy (Global) Ltd AU:TEG	3.581x
Lazydays Holdings Inc NASDAQ:GORV	0.889x
Impax Asset Management Group Plc LSE:IPX	0.186x
TNL Mediagene Ordinary Shares NASDAQ:TNMG	-3.332x
Integrated Media Technology Ltd NASDAQ:IMTE	-0.025x
Castings PLC LSE:CGS	0.124x

Annual Cash Flow Conversion Efficiency for BioSenic S.A. (2012–2024)

The table below shows the annual cash flow conversion efficiency of BioSenic S.A. from 2012 to 2024. View today's stock price for BioSenic S.A. for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-26.81 Million ≈ $-31.34 Million	€-2.23 Million ≈ $-2.61 Million	0.083x	-45.50%
2023-12-31	€-22.70 Million ≈ $-26.54 Million	€-3.47 Million ≈ $-4.06 Million	0.153x	+125.00%
2022-12-31	€3.12 Million ≈ $3.65 Million	€-1.91 Million ≈ $-2.23 Million	-0.611x	-132.35%
2021-12-31	€-6.76 Million ≈ $-7.91 Million	€-12.78 Million ≈ $-14.95 Million	1.890x	+139.07%
2020-12-31	€3.33 Million ≈ $3.89 Million	€-16.08 Million ≈ $-18.80 Million	-4.837x	+4.75%
2019-12-31	€2.05 Million ≈ $2.39 Million	€-10.40 Million ≈ $-12.16 Million	-5.078x	-76.78%
2018-12-31	€4.49 Million ≈ $5.25 Million	€-12.90 Million ≈ $-15.08 Million	-2.873x	+37.87%
2017-12-31	€2.38 Million ≈ $2.79 Million	€-11.02 Million ≈ $-12.88 Million	-4.624x	-521.01%
2016-12-31	€15.27 Million ≈ $17.85 Million	€-11.37 Million ≈ $-13.29 Million	-0.745x	-78.12%
2015-12-31	€28.15 Million ≈ $32.91 Million	€-11.77 Million ≈ $-13.75 Million	-0.418x	-212.50%
2014-12-31	€-9.48 Million ≈ $-11.09 Million	€-3.52 Million ≈ $-4.12 Million	0.372x	+100.71%
2013-12-31	€63.00K ≈ $73.65K	€-3.27 Million ≈ $-3.83 Million	-51.968x	-3284.99%
2012-12-31	€2.64 Million ≈ $3.08 Million	€-4.05 Million ≈ $-4.73 Million	-1.535x	--

About BioSenic S.A.

BR:BIOS Belgium Biotechnology

Market Cap

$1.68 Million

€1.44 Million EUR

Market Cap Rank

#30335 Global

#110 in Belgium

Share Price

€0.00

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.00

All Time High

€20.66